59 filings
Page 2 of 3
8-K
ba6 pgzfi9
2 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:14pm
8-K
kz4juqstn2r
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
wsfv3a ebrcnzrgqpt5i
11 Oct 22
Departure of Directors or Certain Officers
7:15am
8-K
8wjmrr9ckeajocwqtu
11 Aug 22
Other Events
7:10am
8-K
l2g3eud
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
1mqqqik9gp99v
6 Jul 22
Departure of Directors or Certain Officers
7:00am
8-K
zgr zpo55ee
8 Jun 22
Other Events
7:44am
8-K
gjb0untxa3wbhroz1
1 Jun 22
Departure of Directors or Certain Officers
8:00am
8-K
no869pq6
18 May 22
Passage Bio Presents New Interim Clinical and Biomarker
7:16am
8-K
51pdj
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
8-K
7crg3ilq duoqn
15 Mar 22
Other Events
7:10am
8-K
atefbo4t
11 Mar 22
Departure of Directors or Certain Officers
5:00pm
8-K
faneecnwk ux
10 Mar 22
Other Events
7:13am
8-K
vcmsl7bnhkdmmvkza
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
8-K
atm1yp1e b0vq
11 Feb 22
Passage Bio Presents New Interim Clinical Data for Patients with GM1 Gangliosidosis in Imagine-1 Study at 2022 WORLDSymposium
11:00am
8-K
c9nmlszpe1xd xepm
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
hnfjr79
17 Dec 21
Passage Bio Announces Positive Interim Safety and Biomarker Data and Advances Phase 1/2 Trial of PBGM01 in GM1 Gangliosidosis
7:01am
8-K
dotri3z3fai dvx
4 Nov 21
Passage Bio Reports Third Quarter 2021 Financial Results and Provides Recent Business Highlights
8:00am
8-K
smlwe1 x3
1 Nov 21
Departure of Directors or Certain Officers
5:01pm
8-K
60zteuulf7sb5
4 Oct 21
Regulation FD Disclosure
7:31am